KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Oct 19, 2017 $3.24 $3.34 $3.24 $3.30 98 472
Oct 18, 2017 $3.34 $3.38 $3.24 $3.28 103 837
Oct 17, 2017 $3.36 $3.42 $3.24 $3.31 137 094
Oct 16, 2017 $3.40 $3.40 $3.40 $3.40 139 850
Oct 13, 2017 $3.40 $3.60 $3.40 $3.40 200 915
Oct 12, 2017 $3.46 $3.68 $3.38 $3.41 303 153
Oct 11, 2017 $3.62 $3.62 $3.36 $3.41 484 580
Oct 10, 2017 $4.10 $4.78 $3.58 $3.69 1 151 579
Oct 09, 2017 $3.56 $4.18 $3.46 $3.92 333 915
Oct 06, 2017 $3.50 $3.64 $3.34 $3.56 138 592
Oct 05, 2017 $3.60 $3.64 $3.50 $3.60 65 692
Oct 04, 2017 $3.60 $3.80 $3.40 $3.60 124 713
Oct 03, 2017 $3.60 $3.80 $3.60 $3.60 123 836
Oct 02, 2017 $3.60 $3.64 $3.48 $3.58 85 558
Sep 29, 2017 $3.68 $3.68 $3.42 $3.59 109 254
Sep 28, 2017 $3.50 $3.70 $3.46 $3.59 234 164
Sep 27, 2017 $3.54 $3.64 $3.40 $3.50 115 368
Sep 26, 2017 $3.40 $3.40 $3.40 $3.40 121 350
Sep 25, 2017 $3.56 $3.60 $3.42 $3.45 97 005
Sep 22, 2017 $3.60 $3.60 $3.40 $3.60 123 384
Sep 21, 2017 $3.74 $3.74 $3.44 $3.50 280 234
Sep 20, 2017 $3.86 $4.28 $3.72 $3.98 613 867
Sep 19, 2017 $3.66 $3.70 $3.54 $3.70 180 373
Sep 18, 2017 $3.60 $3.66 $3.48 $3.50 116 793
Sep 15, 2017 $3.40 $3.62 $3.32 $3.48 159 713
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT